CME: Severe Uncontrolled Asthma: Assessing Phenotypic-driven Approaches to Treatment

Released: December 18, 2018     Valid for credit through: December 17, 2019

 

Activity Overview

 

An increasing body of evidence continues to define the presence of severe asthma subtypes that do not respond to standard therapies. While there are still no widely accepted definitions of phenotypes in severe asthma, guidelines from the European Respiratory Society and American Thoracic Society suggest that there may be certain characteristics, such as eosinophilic airway inflammation, that may guide health care professionals to tailor a more individualized, targeted treatment approach. In this live satellite symposium, experts in the field will evaluate asthma phenotypes and their implications for the treatment of severe uncontrolled asthma, as well as assess pertinent clinical studies utilizing monoclonal antibodies that target key immunologic mediators in severe asthma. The program will also feature the Wheel of Knowledge, a gaming segment that will reinforce topics discussed in the preceding didactic presentations.

Estimated Time To Complete: 60 minutes

Continue to Activity 


By clicking "Continue to Activity" you attest that you have read and understood the CME required elements.

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma Top story: FDA to Review BLA for Oral Immunotherapy AR101 for Peanut Allergy - Pulmonology Advisor… https://t.co/JSl0Dhdy2k
3hreplyretweetfavorite
Interasma RT @Aller_MD: “VIDEO: #Dupilumab or cyclosporine for treating atopic dermatitis?” https://t.co/sIseou6JYq https://t.co/4h02wi3UUa
6hreplyretweetfavorite
Interasma RT @Aller_MD: “More than one in five infants with a bronchiolitis hospital admission will have a subsequent respiratory-related hospital ad…
6hreplyretweetfavorite
Interasma RT @Aller_MD: “FDA to Review BLA for Oral Immunotherapy AR101 for Peanut #Allergyhttps://t.co/4UDldOOtRd https://t.co/HNeJTDeR9s
6hreplyretweetfavorite
Interasma RT @Aller_MD: 10 startups tackling the problem of high prescription drug costs. Managing payments, connecting consumers to reimbursement op…
6hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma